findmyKOL
Clinical trialNCT01113632CompletedPhase 2Interventional

Ofatumumab for Patients With Previously Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

SponsorSCRI Development Innovations, LLCEnrollment77Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Los Robles

    Thousand Oaks, California, United States

  • Florida Cancer Specialists

    Fort Myers, Florida, United States

  • Woodlands Medical Specialists

    Pensacola, Florida, United States

  • Northeast Georgia Medical Center

    Gainesville, Georgia, United States

  • Providence Medical Group

    Terre Haute, Indiana, United States

  • St. Louis Cancer Care

    Chesterfield, Missouri, United States

  • Portsmouth Regional Hospital

    Portsmouth, New Hampshire, United States

  • Hematology-Oncology Associates of Northern Nj

    Morristown, New Jersey, United States

  • Oncology Hematology Care

    Cincinnati, Ohio, United States

  • the Ohio State University

    Columbus, Ohio, United States

  • South Carolina Oncology Associates

    Columbia, South Carolina, United States

  • Chattanooga Oncology Hematology Associates

    Chattanooga, Tennessee, United States

  • Tennessee Oncology

    Nashville, Tennessee, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Jul 2010
Primary completion
31 Mar 2015
Completion
31 Aug 2016
Last update posted
20 Sept 2016
Registered enrollment
77
Registry id
NCT01113632

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.